Blood test and survey combo could spot vulva cancer return earlier

NCT ID NCT06495554

First seen May 02, 2026 · Last updated May 09, 2026 · Updated 1 time

Summary

This study looks at whether regular patient questionnaires and a special blood test (circulating tumor DNA) can detect vulva cancer recurrence earlier than standard follow-up. About 295 women with vulva cancer will be followed for two years, and their results will be compared to 1000 historical cases. The goal is to improve surveillance and quality of life, not to test a new treatment.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for VULVA CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Aarhus University Hospital

    RECRUITING

    Aarhus N, 8200, Denmark

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Copenhagen University Hospital

    RECRUITING

    Copenhagen, 2100, Denmark

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.